Central Line Insertion Indications

Primary Clinical Indications

The American College of Physicians recommends central venous catheters for patients requiring long-term intravenous therapy (>5-14 days), administering vesicant/irritant medications or high-osmolarity solutions, or needing central venous access for hemodynamic monitoring or specific therapies like parenteral nutrition or chemotherapy 1, 2
Non-tunneled central catheters are indicated for short-term use (typically <30 days) when peripheral venous access is unachievable, according to the Annals of Oncology 3, 4
Tunneled central catheters should be used when long-term access (>30 days) is required for chemotherapy, antibiotics, parenteral nutrition, or blood products, as recommended by the Annals of Oncology 3, 4
Implantable ports are indicated for long-term intermittent therapy (≥6 months) and carry the lowest infection risk among long-term devices, according to the Annals of Internal Medicine 3, 5

For oncology patients, the American Society of Clinical Oncology recommends short-term chemotherapy (<3 months): interval placement of peripheral IV catheters with each treatment, with PICCs as an alternative if peripheral access fails 5
For critically ill patients, the Society of Critical Care Medicine recommends peripherally compatible infusates: PICCs are inappropriate unless duration is ≥15 days; use peripheral IV (≤5 days) or midline catheters (6-14 days) instead 5
For patients with chronic kidney disease, the National Kidney Foundation recommends restricting venous access and using small-bore catheters via internal jugular vein when central access is necessary 2

The American College of Surgeons recommends avoiding femoral vein access unless contraindications exist to other sites, as it carries 10 times higher thrombosis risk than subclavian access and increased infection risk 1, 2, 3, 8
Subclavian access is associated with lower catheter-related bloodstream infection rates compared to femoral and possibly jugular sites, according to the American College of Surgeons 2

The Centers for Disease Control and Prevention strongly recommend ultrasound guidance for all CVC insertions to increase success rates and reduce complications, including pneumothorax, arterial puncture, and air embolism 1, 2
Maximal sterile barrier precautions must be applied, including cap, mask, sterile gown, sterile gloves, and sterile full-body drape, as recommended by the Centers for Disease Control and Prevention 2
Chlorhexidine 0.5% with alcohol is recommended for skin preparation, according to the Centers for Disease Control and Prevention 2, 3